Market Research Logo

Respiratory Inhaler Devices Market: Metered Dose Inhaler Most Lucrative Product Type Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Respiratory Inhaler Devices Market: Metered Dose Inhaler Most Lucrative Product Type Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Future Market Insights offers 10-year forecast on the global respiratory inhaler devices market between 2017 and 2027. This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the global respiratory inhaler devices market over the forecast period. The global respiratory inhaler device market report provides analysis and insights on respiratory inhalers. Primary factors fuelling demand for respiratory inhaler device market are increasing prevalence of asthma, COPD and other respiratory diseases coupled with rising awareness that has triggered the usage of respiratory inhaler devices worldwide. This is expected to bolster the growth of the respiratory inhaler devices market over the next five to six years. Increasing demand for respiratory inhaler devices for controlling asthma and other respiratory disease, especially among children and elderly population, is expected to drive growth of respiratory inhaler devices market during the forecast period. Companies are focusing on regions and sections where prevalence of asthma, and chronic lung diseases are increasing such as Asia Pacific and MEA.

To understand and assess various opportunities in this market, the report is categorically split into four sections, namely market analysis by product type, technology, disease indication and region. The report analyses the global respiratory inhaler device market in terms of value (US$ Mn).

The report starts with an overview of the global respiratory inhaler device. In the same section, FMI covers the global respiratory inhaler device market performance in terms of value. This section also includes FMI’s analysis of key trends, drivers, and restraints from supply and demand perspectives. The report also cover the opportunities in the global respiratory inhaler device market.

The next section of the report analyses the market on the basis of respiratory inhaler device market segment and presents the forecast in terms of value for all years till 2027. The market has been segmented as follows:

By Product Type

Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Ultrasonic Nebulizer
Compressed Air Nebulizer
Mesh Nebulizer
By Technology

Manually Operated Inhaler Devices
Digitally Operated Inhaler Devices
By Disease Indication

Asthma
COPD
Pulmonary Arterial Hypertension
Others Respiratory Disease
The next section analyses the market on the basis of regions in terms of value for the forecast period. Regions covered in the report are as follows

By Region

North America
U.S.
Canada
Latin America
Argentina
Brazil
Mexico
Rest of LA
Western Europe
Germany
France
U.K
Italy
Spain
Nordic
BENELUX
Rest of WE
Eastern Europe
Poland
Russia
Rest of EE
Asia Pacific Excluding Japan
China
India
Australia &b New Zealand
ASEAN
Rest of APEJ
Japan
Middle East & Africa
GCC countries
South Africa
North Africa
Rest of MEA
To reach market size, the report considers market value of the global respiratory inhaler device across the above-mentioned regions. The market estimation presented in the report evaluates the total revenue generated in the global respiratory inhaler device market over the forecast period. When developing the market forecast, the starting point involves sizing up the current market, which forms the basis of the forecast. For this, FMI conducted interviews with several subject matter experts in the respiratory inhaler device domain across the globe. Given the scenario of the market, FMI triangulated the outcome based on analysis from the supply side, demand side and also the dynamics of the market. In this report, quantification of data has been conducted along with qualitative analysis.

We have also taken into consideration the year-on-year growth of the global respiratory inhaler device market, based on regional growth analysis, to understand the predictability of the market and to identify the key opportunities. Another key feature of this report is the analysis of the global respiratory inhaler device market, by region, which is further segmented on the basis of countries and revenue forecast in terms of absolute dollar (US$) opportunity. Regional trends have been introspected, identified and applied while carrying out the forecasting of the market. Additionally, the absolute dollar opportunity provided in the report is critical in assessing the level of opportunity that a provider can look to achieve from a sales perspective in the global respiratory inhaler device market.


1. Executive Summary
1.1. Overview
1.2. FMI Analysis and Recommendations
1.3. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Respiratory Inhaler Devices Market View Point
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Regulatory Scenario
3.4. Respiratory Inhaler Devices Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Trends
4. North America Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016
4.2.1. U.S.
4.2.2. Canada
4.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
4.3.1. U.S.
4.3.2. Canada
4.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016
4.4.1. Dry Powder Inhaler
4.4.2. Metered Dose Inhaler
4.4.3. Nebulizer
4.4.3.1. Compressed Air Nebulizers
4.4.3.2. Ultrasonic Nebulizers
4.4.3.3. Mesh Nebulizers
4.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027
4.5.1. Dry Powder Inhaler
4.5.2. Metered Dose Inhaler
4.5.3. Nebulizer
4.5.3.1. Compressed Air Nebulizers
4.5.3.2. Ultrasonic Nebulizers
4.5.3.3. Mesh Nebulizers
4.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016
4.6.1. Manually Operated Inhaler Devices
4.6.2. Digitally Operated Inhaler Devices
4.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027
4.7.1. Manually Operated Inhaler Devices
4.7.2. Digitally Operated Inhaler Devices
4.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016
4.8.1. Asthma
4.8.2. COPD
4.8.3. Pulmonary Arterial Hypertension
4.8.4. Others Respiratory Disease
4.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027
4.9.1. Asthma
4.9.2. COPD
4.9.3. Pulmonary Arterial Hypertension
4.9.4. Others Respiratory Disease
4.10. Drivers and Restraints: Impact Analysis
4.11. Market Attractiveness Analysis
4.11.1. By Country
4.11.2. By Product
4.11.3. By Technology
4.11.4. Disease Indication
5. Latin America Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016
5.2.1. Brazil
5.2.2. Mexico
5.2.3. Rest of Latin America
5.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016
5.4.1. Dry Powder Inhaler
5.4.2. Metered Dose Inhaler
5.4.3. Nebulizer
5.4.3.1. Compressed Air Nebulizers
5.4.3.2. Ultrasonic Nebulizers
5.4.3.3. Mesh Nebulizers
5.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027
5.5.1. Dry Powder Inhaler
5.5.2. Metered Dose Inhaler
5.5.3. Nebulizer
5.5.3.1. Compressed Air Nebulizers
5.5.3.2. Ultrasonic Nebulizers
5.5.3.3. Mesh Nebulizers
5.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016
5.6.1. Manually Operated Inhaler Devices
5.6.2. Digitally Operated Inhaler Devices
5.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027
5.7.1. Manually Operated Inhaler Devices
5.7.2. Digitally Operated Inhaler Devices
5.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016
5.8.1. Asthma
5.8.2. COPD
5.8.3. Pulmonary Arterial Hypertension
5.8.4. Others Respiratory Disease
5.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027
5.9.1. Asthma
5.9.2. COPD
5.9.3. Pulmonary Arterial Hypertension
5.9.4. Others Respiratory Disease
5.10. Drivers and Restraints: Impact Analysis
5.11. Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Product
5.11.3. By Technology
5.11.4. Disease Indication
6. Western Europe Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016
6.2.1. Germany
6.2.2. Italy
6.2.3. France
6.2.4. Spain
6.2.5. U.K.
6.2.6. BENELUX
6.2.7. Nordic
6.2.8. Rest of Western Europe
6.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
6.3.1. Germany
6.3.2. Italy
6.3.3. France
6.3.4. Spain
6.3.5. U.K.
6.3.6. BENELUX
6.3.7. Nordic
6.3.8. Rest of Western Europe
6.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016
6.4.1. Dry Powder Inhaler
6.4.2. Metered Dose Inhaler
6.4.3. Nebulizer
6.4.3.1. Compressed Air Nebulizers
6.4.3.2. Ultrasonic Nebulizers
6.4.3.3. Mesh Nebulizers
6.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027
6.5.1. Dry Powder Inhaler
6.5.2. Metered Dose Inhaler
6.5.3. Nebulizer
6.5.3.1. Compressed Air Nebulizers
6.5.3.2. Ultrasonic Nebulizers
6.5.3.3. Mesh Nebulizers
6.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016
6.6.1. Manually Operated Inhaler Devices
6.6.2. Digitally Operated Inhaler Devices
6.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027
6.7.1. Manually Operated Inhaler Devices
6.7.2. Digitally Operated Inhaler Devices
6.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016
6.8.1. Asthma
6.8.2. COPD
6.8.3. Pulmonary Arterial Hypertension
6.8.4. Others Respiratory Disease
6.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027
6.9.1. Asthma
6.9.2. COPD
6.9.3. Pulmonary Arterial Hypertension
6.9.4. Others Respiratory Disease
6.10. Drivers and Restraints: Impact Analysis
6.11. Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Product
6.11.3. By Technology
6.11.4. Disease Indication
7. Eastern Europe Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016
7.2.1. Russia
7.2.2. Poland
7.2.3. Rest of Eastern Europe
7.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016
7.4.1. Dry Powder Inhaler
7.4.2. Metered Dose Inhaler
7.4.3. Nebulizer
7.4.3.1. Compressed Air Nebulizers
7.4.3.2. Ultrasonic Nebulizers
7.4.3.3. Mesh Nebulizers
7.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027
7.5.1. Dry Powder Inhaler
7.5.2. Metered Dose Inhaler
7.5.3. Nebulizer
7.5.3.1. Compressed Air Nebulizers
7.5.3.2. Ultrasonic Nebulizers
7.5.3.3. Mesh Nebulizers
7.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016
7.6.1. Manually Operated Inhaler Devices
7.6.2. Digitally Operated Inhaler Devices
7.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027
7.7.1. Manually Operated Inhaler Devices
7.7.2. Digitally Operated Inhaler Devices
7.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016
7.8.1. Asthma
7.8.2. COPD
7.8.3. Pulmonary Arterial Hypertension
7.8.4. Others Respiratory Disease
7.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027
7.9.1. Asthma
7.9.2. COPD
7.9.3. Pulmonary Arterial Hypertension
7.9.4. Others Respiratory Disease
7.10. Drivers and Restraints: Impact Analysis
7.11. Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Product
7.11.3. By Technology
7.11.4. Disease Indication
8. Asia Pacific excluding Japan Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016
8.2.1. China
8.2.2. India
8.2.3. ASEAN
8.2.4. Australia and New Zealand
8.2.5. Rest of APEJ
8.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
8.3.1. China
8.3.2. India
8.3.3. ASEAN
8.3.4. Australia and New Zealand
8.3.5. Rest of APEJ
8.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016
8.4.1. Dry Powder Inhaler
8.4.2. Metered Dose Inhaler
8.4.3. Nebulizer
8.4.3.1. Compressed Air Nebulizers
8.4.3.2. Ultrasonic Nebulizers
8.4.3.3. Mesh Nebulizers
8.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027
8.5.1. Dry Powder Inhaler
8.5.2. Metered Dose Inhaler
8.5.3. Nebulizer
8.5.3.1. Compressed Air Nebulizers
8.5.3.2. Ultrasonic Nebulizers
8.5.3.3. Mesh Nebulizers
8.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016
8.6.1. Manually Operated Inhaler Devices
8.6.2. Digitally Operated Inhaler Devices
8.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027
8.7.1. Manually Operated Inhaler Devices
8.7.2. Digitally Operated Inhaler Devices
8.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016
8.8.1. Asthma
8.8.2. COPD
8.8.3. Pulmonary Arterial Hypertension
8.8.4. Others Respiratory Disease
8.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027
8.9.1. Asthma
8.9.2. COPD
8.9.3. Pulmonary Arterial Hypertension
8.9.4. Others Respiratory Disease
8.10. Drivers and Restraints: Impact Analysis
8.11. Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Product
8.11.3. By Technology
8.11.4. Disease Indication
9. Japan Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016
9.2.1. Dry Powder Inhaler
9.2.2. Metered Dose Inhaler
9.2.3. Nebulizer
9.2.3.1. Compressed Air Nebulizers
9.2.3.2. Ultrasonic Nebulizers
9.2.3.3. Mesh Nebulizers
9.3. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027
9.3.1. Dry Powder Inhaler
9.3.2. Metered Dose Inhaler
9.3.3. Nebulizer
9.3.3.1. Compressed Air Nebulizers
9.3.3.2. Ultrasonic Nebulizers
9.3.3.3. Mesh Nebulizers
9.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016
9.4.1. Manually Operated Inhaler Devices
9.4.2. Digitally Operated Inhaler Devices
9.5. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027
9.5.1. Manually Operated Inhaler Devices
9.5.2. Digitally Operated Inhaler Devices
9.6. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016
9.6.1. Asthma
9.6.2. COPD
9.6.3. Pulmonary Arterial Hypertension
9.6.4. Others Respiratory Disease
9.7. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027
9.7.1. Asthma
9.7.2. COPD
9.7.3. Pulmonary Arterial Hypertension
9.7.4. Others Respiratory Disease
9.8. Drivers and Restraints: Impact Analysis
9.9. Market Attractiveness Analysis
9.9.1. By Product
9.9.2. By Technology
9.9.3. Disease Indication
10. Middle East & Africa Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016
10.2.1. GCC Countries
10.2.2. Northern Africa
10.2.3. South Africa
10.2.4. Rest of MEA
10.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027
10.3.1. GCC Countries
10.3.2. Northern Africa
10.3.3. South Africa
10.3.4. Rest of MEA
10.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016
10.4.1. Dry Powder Inhaler
10.4.2. Metered Dose Inhaler
10.4.3. Nebulizer
10.4.3.1. Compressed Air Nebulizers
10.4.3.2. Ultrasonic Nebulizers
10.4.3.3. Mesh Nebulizers
10.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027
10.5.1. Dry Powder Inhaler
10.5.2. Metered Dose Inhaler
10.5.3. Nebulizer
10.5.3.1. Compressed Air Nebulizers
10.5.3.2. Ultrasonic Nebulizers
10.5.3.3. Mesh Nebulizers
10.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016
10.6.1. Manually Operated Inhaler Devices
10.6.2. Digitally Operated Inhaler Devices
10.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027
10.7.1. Manually Operated Inhaler Devices
10.7.2. Digitally Operated Inhaler Devices
10.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016
10.8.1. Asthma
10.8.2. COPD
10.8.3. Pulmonary Arterial Hypertension
10.8.4. Others Respiratory Disease
10.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027
10.9.1. Asthma
10.9.2. COPD
10.9.3. Pulmonary Arterial Hypertension
10.9.4. Others Respiratory Disease
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Product
10.11.3. By Technology
10.11.4. Disease Indication
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Competition Dashboard
13.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
13.2.1. AstraZeneca
13.2.2. Beximco Pharmaceuticals Ltd.
13.2.3. Boehringer Ingelheim GmbH
13.2.4. Cipla Ltd.
13.2.5. GlaxoSmithKline plc
13.2.6. Koninklijke Philips N.V.
13.2.7. Merck & Co., Inc.
13.2.8. OMRON Healthcare Europe B.V.
13.2.9. PARI Medical Holding
13.2.10. Teva Pharmaceutical Industries Ltd
14. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027, By Region
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Region, 2012–2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Asia Pacific excluding Japan
14.2.6. Japan
14.2.7. Middle East & Africa
14.3. Market Size (US$ Mn) and Volume Forecast By Region, 2017–2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Asia Pacific excluding Japan
14.3.6. Japan
14.3.7. Middle East & Africa
14.4. Market Attractiveness Analysis By Region
15. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027, By Product
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016
15.2.1. Dry Powder Inhaler
15.2.2. Metered Dose Inhaler
15.2.3. Nebulizer
15.2.3.1. Compressed Air Nebulizers
15.2.3.2. Ultrasonic Nebulizers
15.2.3.3. Mesh Nebulizers
15.3. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027
15.3.1. Dry Powder Inhaler
15.3.2. Metered Dose Inhaler
15.3.3. Nebulizer
15.3.3.1. Compressed Air Nebulizers
15.3.3.2. Ultrasonic Nebulizers
15.3.3.3. Mesh Nebulizers
15.4. Market Attractiveness Analysis By Product
16. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027, Technology
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016
16.2.1. Manually Operated Inhaler Devices
16.2.2. Digitally Operated Inhaler Devices
16.3. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027
16.3.1. Manually Operated Inhaler Devices
16.3.2. Digitally Operated Inhaler Devices
16.4. Market Attractiveness Analysis Disease Indication
17. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027, Disease Indication
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016
17.2.1. Asthma
17.2.2. COPD
17.2.3. Pulmonary Arterial Hypertension
17.2.4. Others Respiratory Disease
17.3. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027
17.3.1. Asthma
17.3.2. COPD
17.3.3. Pulmonary Arterial Hypertension
17.3.4. Others Respiratory Disease
17.4. Market Attractiveness Analysis Disease Indication
18. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027
18.1. Market Size and Y-o-Y Growth
18.2. Absolute $ Opportunity
List of Tables
Table 01: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 02: North America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 03: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 04: North America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 05: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 06: North America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 07: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 08: North America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 09: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 10: Latin America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 11: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 12: Latin America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 13: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 14: Latin America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 15: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 16: Latin America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 17: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 18: Western Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 19: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 20: Western Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 21: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 22: Western Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 23: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 24: Western Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 25: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 26: Eastern Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 27: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 28: Eastern Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 29: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 30: Eastern Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 31: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 32: Eastern Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 33: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 34: APEJ Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 35: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 36: APEJ Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 37: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 38: APEJ Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 39: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 40: APEJ Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 41: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 42: Japan Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 43: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 44: Japan Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 45: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 46: Japan Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 47: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 48: MEA Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 49: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 50: MEA Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 51: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 52: MEA Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology
Table 53: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 54: MEA Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication
Table 55: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Region, 2012–2017
Table 56: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Region, 2012–2017
Table 57: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Product Type, 2012–2017
Table 58: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Product Type, 2012–2017
Table 59: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Technology, 2012–2017
Table 60: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Technology, 2012–2017
Table 61: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Disease Indication, 2012–2017
Table 62: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Disease Indication, 2012–2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report